Blog Category




Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Onco...

March 19th, 2019

Mihir Shah of UE LifeSciences Inc. has been selected as the winner of the 2019 Lyfebulb-Helsinn Innovation Award in Oncology Pierluigi Paracchi of Gen...

Read article

Helsinn initiates two new global Phase III studies with anamorelin

March 7th, 2019

Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non small cell lung cancer (NSCLC) and...

Read article


Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation...

February 27th, 2019

The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using therapeutics, diagnostics, medical devices or heal...

Read article